Recruiting Polycystic Kidney Disease Studies in New Haven
About Polycystic Kidney Disease Clinical Trials in New Haven
Polycystic kidney disease (PKD) is a genetic disorder causing numerous fluid-filled cysts to grow in the kidneys, leading to kidney enlargement and progressive loss of function. Autosomal dominant PKD is the most common form. Treatment includes tolvaptan and management of complications.
There are currently 2 polycystic kidney disease clinical trials recruiting participants in New Haven, CT. These studies are seeking a combined 264 participants. Research is being sponsored by AbbVie, Vertex Pharmaceuticals Incorporated. Clinical trial participation is free and participants receive study-related medical care at no cost.
Polycystic Kidney Disease Clinical Trials in New Haven — FAQ
Are there polycystic kidney disease clinical trials in New Haven?
Yes, there are 2 polycystic kidney disease clinical trials currently recruiting in New Haven, CT. Browse the studies on this page to find one that fits.
How do I join a clinical trial in New Haven?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New Haven research site will contact you about next steps.
Are clinical trials in New Haven free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New Haven studies also compensate for your time and travel.
What polycystic kidney disease treatments are being tested?
The 2 active trials in New Haven are testing new therapies including novel drugs, biologics, and treatment approaches for polycystic kidney disease.
Data updated July 13, 2026 from ClinicalTrials.gov